Get the Stockscreener App
4.31
5.07%
-0.23
After Hours:
4.50
0.19
+4.41%
Arcadia Biosciences Inc stock is traded at $4.31, with a volume of 2,027.
It is down -5.07% in the last 24 hours and down -4.65% over the past month.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
See More
Previous Close:
$4.54
Open:
$4.52
24h Volume:
2,027
Relative Volume:
0.13
Market Cap:
$5.89M
Revenue:
$5.67M
Net Income/Loss:
$-13.98M
P/E Ratio:
-0.305
EPS:
-14.13
Net Cash Flow:
$-15.30M
1W Performance:
-9.07%
1M Performance:
-4.65%
6M Performance:
-17.12%
1Y Performance:
+40.16%
1-Day Range:
$4.3001
$4.52
1-Week Range:
$4.30
$4.74
52-Week Range:
$2.40
$10.31
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Name
Arcadia Biosciences Inc
Sector
Industry
Phone
530-756-7077
Address
202 COUSTEAU PLACE, DAVIS, CA
Compare RKDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
4.31 | 6.48M | 5.67M | -13.98M | -15.30M | -14.13 |
|
KHC
Kraft Heinz Co
|
28.78 | 32.10B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
13.19 | 28.79B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
K
Kellanova
|
80.09 | 27.56B | 12.63B | 1.38B | 863.00M | 3.96 |
|
GIS
General Mills Inc
|
50.95 | 27.13B | 19.64B | 2.56B | 2.48B | 4.55 |
|
MKC
Mccormick Co Inc
|
72.50 | 18.99B | 6.68B | 792.60M | 774.40M | 2.94 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-20 | Reiterated | H.C. Wainwright | Buy |
| May-12-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-09-15 | Initiated | Credit Suisse | Outperform |
| Jun-09-15 | Initiated | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Stock (RKDA) Latest News
What drives Arcadia Biosciences Inc. stock priceConsistently outstanding ROI - jammulinksnews.com
What analysts say about Arcadia Biosciences Inc. stockExceptional profit velocity - jammulinksnews.com
Arcadia Biosciences Inc. Stock Analysis and ForecastExtraordinary profit generation - jammulinksnews.com
What makes Arcadia Biosciences Inc. stock price move sharplyTriple Return With Stability - Newser
Bactericide Market Competitive Landscape and Company Profiles Report 2025 - Yahoo.co
Is Arcadia Biosciences Inc. a good long term investmentConsistently outstanding ROI - PrintWeekIndia
Will Arcadia Biosciences Inc. stock benefit from AI tech trendsTrending Stock Alert - Newser
Cority Continues to Be a Leader in the Sustainability Software Market, According to Prominent Industry Analyst Report - GlobeNewswire Inc.
How Arcadia Biosciences Inc. stock performs during market volatilityFree Predictions - Newser
Why Arcadia Biosciences Inc. stock attracts strong analyst attentionInvestor Friendly Risk Reward - Newser
Agricultural Biotechnology Market Outlook Report to 2030, with Profiles of Bayer, Corteva, Syngenta, BASF, FMC, Bioceres Crop Solutions, Evogene, Marrone Bio Innovations, Calyxt & Arcadia Biosciences - Yahoo Finance
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com - Defense World
Arcadia Biosciences faces default on $2M note payment By Investing.com - Investing.com India
Arcadia Biosciences faces default on $2M note payment - Investing.com
Arcadia Biosciences Faces Payment Default from Above Food - TipRanks
Arcadia Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow
SEC Form 4 filed by Chief Financial Officer Kawakami Mark - Quantisnow
SEC Form 4 filed by Chief Executive Officer Schaefer Thomas J. - Quantisnow
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences Reports Strong Growth Amid Challenges - TipRanks
Arcadia Biosciences: Q1 Earnings Snapshot - New Haven Register
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and ... - Yahoo Finance
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and Strategic Moves Amid Challenges - GuruFocus
Earnings call transcript: Arcadia Biosciences sees Q1 2025 revenue rise 22% - Investing.com
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Arcadia Biosciences Q1 Earnings Preview - MSN
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Arcadia Climbs on Q1 Figures - Baystreet.ca
ARCADIA BIOSCIENCES Earnings Results: $RKDA Reports Quarterly Earnings - Nasdaq
Arcadia Biosciences Inc Stock (RKDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):